Recent Trends in Nanodrug Delivery - Alan Minsk
Recent Trends in Nanodrug Delivery - Innovative Technologies and Commercial Viability…
One of the greatest impacts of nanomedicine is likely to take place in the context of drug delivery, which is poised to deliver to the market both evolutionary and revolutionary nanomedicines and devices. Early forecasts for nanomedicine commercialization are encouraging. However, there are challenges as well - formidable legal, policy, ethical and regulatory questions as well as emerging thickets of overlapping patent claims.
Currently, patent systems are under greater scrutiny and strain, with patent offices around the world continuing to struggle with evaluating the swarm of nanomedicine-related patent applications. Given this backdrop, it is natural to question whether advances in the laboratory will result in viable commercial products that benefit society.
Watch This Presentation (in new window).
Alan Minsk JD is a Partner and Chair of the Food & Drug Practice Team of Arnall Golden Gregory LLP, located in Atlanta, Georgia.
Prior to returning home to Atlanta and his association with Arnall Golden, he worked with a Washington, D.C. food and drug law firm.
Mr. Minsk advises pharmaceutical, medical device, and food companies on all legal and regulatory matters relating to the U.S. Food and Drug Administration, and certain matters concerning the U.S. Department of Agriculture, the Federal Trade Commission, the Drug Enforcement Administration, the Bureau of Alcohol, Tobacco and Firearms, and the Consumer Product Safety Commission.
He counsels clients and has spoken and written on a wide variety of FDA-related issues, including regulatory strategies and life cycle management, combination products, FDA enforcement, FDA inspections, corporate compliance, market exclusivity, product promotion and advertising, product liability, clinical trials and imports and exports.
He serves on the editorial advisory boards of the Pharmaceutical Formulation & Quality and the Law Journal Newsletters’ Product Liability Law & Strategy journals and was recently appointed to the University of Georgia College of Pharmacy Regulatory Affairs Advisory Board.
Discussion
No comments for “Recent Trends in Nanodrug Delivery - Alan Minsk”
Post a comment